nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS3—Doxorubicin—pancreatic cancer	0.183	0.31	CbGbCtD
Metformin—NDUFS7—Doxorubicin—pancreatic cancer	0.183	0.31	CbGbCtD
Metformin—NDUFS2—Doxorubicin—pancreatic cancer	0.183	0.31	CbGbCtD
Metformin—SLC22A3—Irinotecan—pancreatic cancer	0.0418	0.0707	CbGbCtD
Metformin—ND4L—gall bladder—pancreatic cancer	0.00274	0.0181	CbGeAlD
Metformin—ND3—gall bladder—pancreatic cancer	0.00274	0.0181	CbGeAlD
Metformin—ND5—gall bladder—pancreatic cancer	0.00274	0.0181	CbGeAlD
Metformin—ND2—gall bladder—pancreatic cancer	0.00274	0.0181	CbGeAlD
Metformin—ND4—gall bladder—pancreatic cancer	0.00266	0.0175	CbGeAlD
Metformin—ND6—gall bladder—pancreatic cancer	0.0024	0.0158	CbGeAlD
Metformin—SLC29A4—islet of Langerhans—pancreatic cancer	0.00235	0.0155	CbGeAlD
Metformin—NDUFS4—gall bladder—pancreatic cancer	0.0022	0.0145	CbGeAlD
Metformin—NDUFA8—gall bladder—pancreatic cancer	0.00214	0.0141	CbGeAlD
Metformin—NDUFB8—gall bladder—pancreatic cancer	0.0021	0.0139	CbGeAlD
Metformin—NDUFA2—islet of Langerhans—pancreatic cancer	0.00171	0.0113	CbGeAlD
Metformin—NDUFA10—islet of Langerhans—pancreatic cancer	0.00163	0.0107	CbGeAlD
Metformin—NDUFAF3—pancreas—pancreatic cancer	0.00161	0.0107	CbGeAlD
Metformin—NDUFC1—islet of Langerhans—pancreatic cancer	0.00161	0.0107	CbGeAlD
Metformin—NDUFB2—islet of Langerhans—pancreatic cancer	0.0016	0.0106	CbGeAlD
Metformin—NDUFAF1—islet of Langerhans—pancreatic cancer	0.00159	0.0105	CbGeAlD
Metformin—NDUFAF2—islet of Langerhans—pancreatic cancer	0.00156	0.0103	CbGeAlD
Metformin—NDUFB3—islet of Langerhans—pancreatic cancer	0.00156	0.0103	CbGeAlD
Metformin—NDUFA5—islet of Langerhans—pancreatic cancer	0.00152	0.0101	CbGeAlD
Metformin—NDUFA11—islet of Langerhans—pancreatic cancer	0.00152	0.0101	CbGeAlD
Metformin—NDUFS6—digestive system—pancreatic cancer	0.00152	0.01	CbGeAlD
Metformin—NDUFB6—islet of Langerhans—pancreatic cancer	0.00151	0.00999	CbGeAlD
Metformin—NDUFAF4—islet of Langerhans—pancreatic cancer	0.00151	0.00999	CbGeAlD
Metformin—NDUFS1—islet of Langerhans—pancreatic cancer	0.0015	0.00992	CbGeAlD
Metformin—NDUFB10—islet of Langerhans—pancreatic cancer	0.00149	0.00985	CbGeAlD
Metformin—NDUFB7—islet of Langerhans—pancreatic cancer	0.00148	0.00978	CbGeAlD
Metformin—NDUFA12—islet of Langerhans—pancreatic cancer	0.00148	0.00978	CbGeAlD
Metformin—NDUFS8—islet of Langerhans—pancreatic cancer	0.00147	0.00971	CbGeAlD
Metformin—NDUFB1—islet of Langerhans—pancreatic cancer	0.00147	0.00971	CbGeAlD
Metformin—NDUFA6—islet of Langerhans—pancreatic cancer	0.00145	0.00958	CbGeAlD
Metformin—NDUFB5—islet of Langerhans—pancreatic cancer	0.00145	0.00958	CbGeAlD
Metformin—NDUFS4—islet of Langerhans—pancreatic cancer	0.00144	0.00951	CbGeAlD
Metformin—NDUFA7—Azacitidine—Gemcitabine—pancreatic cancer	0.00144	0.383	CbGdCrCtD
Metformin—NDUFB4—islet of Langerhans—pancreatic cancer	0.00142	0.00939	CbGeAlD
Metformin—NDUFAB1—islet of Langerhans—pancreatic cancer	0.00141	0.00933	CbGeAlD
Metformin—NDUFA8—islet of Langerhans—pancreatic cancer	0.0014	0.00928	CbGeAlD
Metformin—NDUFB9—islet of Langerhans—pancreatic cancer	0.0014	0.00928	CbGeAlD
Metformin—NDUFA4—islet of Langerhans—pancreatic cancer	0.0014	0.00922	CbGeAlD
Metformin—NDUFV1—islet of Langerhans—pancreatic cancer	0.00139	0.00916	CbGeAlD
Metformin—NDUFB11—islet of Langerhans—pancreatic cancer	0.00139	0.00916	CbGeAlD
Metformin—NDUFB8—islet of Langerhans—pancreatic cancer	0.00138	0.00911	CbGeAlD
Metformin—NDUFS5—islet of Langerhans—pancreatic cancer	0.00138	0.00911	CbGeAlD
Metformin—NDUFAF3—digestive system—pancreatic cancer	0.00138	0.00911	CbGeAlD
Metformin—ND1—gall bladder—pancreatic cancer	0.00134	0.00885	CbGeAlD
Metformin—NDUFS7—islet of Langerhans—pancreatic cancer	0.00129	0.00854	CbGeAlD
Metformin—ND5—pancreas—pancreatic cancer	0.00126	0.00835	CbGeAlD
Metformin—ND3—pancreas—pancreatic cancer	0.00126	0.00835	CbGeAlD
Metformin—ND2—pancreas—pancreatic cancer	0.00126	0.00835	CbGeAlD
Metformin—ND4L—pancreas—pancreatic cancer	0.00126	0.00835	CbGeAlD
Metformin—NDUFA13—digestive system—pancreatic cancer	0.00124	0.00816	CbGeAlD
Metformin—NDUFA9—digestive system—pancreatic cancer	0.00124	0.00816	CbGeAlD
Metformin—ND4—pancreas—pancreatic cancer	0.00122	0.00808	CbGeAlD
Metformin—NDUFA2—Azacitidine—Gemcitabine—pancreatic cancer	0.00122	0.326	CbGdCrCtD
Metformin—NDUFA1—digestive system—pancreatic cancer	0.00122	0.00803	CbGeAlD
Metformin—NDUFA2—pancreas—pancreatic cancer	0.0012	0.00792	CbGeAlD
Metformin—PRKAB1—islet of Langerhans—pancreatic cancer	0.00118	0.00781	CbGeAlD
Metformin—NDUFV2—digestive system—pancreatic cancer	0.00118	0.0078	CbGeAlD
Metformin—NDUFA10—pancreas—pancreatic cancer	0.00114	0.00755	CbGeAlD
Metformin—NDUFC1—pancreas—pancreatic cancer	0.00113	0.00749	CbGeAlD
Metformin—NDUFB2—pancreas—pancreatic cancer	0.00112	0.00742	CbGeAlD
Metformin—NDUFAF1—pancreas—pancreatic cancer	0.00111	0.00736	CbGeAlD
Metformin—ND6—pancreas—pancreatic cancer	0.00111	0.0073	CbGeAlD
Metformin—NDUFAF2—pancreas—pancreatic cancer	0.0011	0.00724	CbGeAlD
Metformin—NDUFB3—pancreas—pancreatic cancer	0.0011	0.00724	CbGeAlD
Metformin—NDUFB3—Azacitidine—Gemcitabine—pancreatic cancer	0.00109	0.291	CbGdCrCtD
Metformin—ND4L—digestive system—pancreatic cancer	0.00108	0.00713	CbGeAlD
Metformin—ND2—digestive system—pancreatic cancer	0.00108	0.00713	CbGeAlD
Metformin—ND3—digestive system—pancreatic cancer	0.00108	0.00713	CbGeAlD
Metformin—ND5—digestive system—pancreatic cancer	0.00108	0.00713	CbGeAlD
Metformin—NDUFA11—pancreas—pancreatic cancer	0.00107	0.00707	CbGeAlD
Metformin—NDUFA5—pancreas—pancreatic cancer	0.00107	0.00707	CbGeAlD
Metformin—NDUFS2—islet of Langerhans—pancreatic cancer	0.00107	0.00707	CbGeAlD
Metformin—NDUFAF4—pancreas—pancreatic cancer	0.00106	0.00702	CbGeAlD
Metformin—NDUFB6—pancreas—pancreatic cancer	0.00106	0.00702	CbGeAlD
Metformin—NDUFS3—islet of Langerhans—pancreatic cancer	0.00106	0.00699	CbGeAlD
Metformin—NDUFS1—pancreas—pancreatic cancer	0.00106	0.00697	CbGeAlD
Metformin—NDUFB10—pancreas—pancreatic cancer	0.00105	0.00692	CbGeAlD
Metformin—ND4—digestive system—pancreatic cancer	0.00105	0.0069	CbGeAlD
Metformin—NDUFB7—pancreas—pancreatic cancer	0.00104	0.00687	CbGeAlD
Metformin—NDUFA12—pancreas—pancreatic cancer	0.00104	0.00687	CbGeAlD
Metformin—NDUFB1—pancreas—pancreatic cancer	0.00103	0.00682	CbGeAlD
Metformin—NDUFS8—pancreas—pancreatic cancer	0.00103	0.00682	CbGeAlD
Metformin—NDUFB5—pancreas—pancreatic cancer	0.00102	0.00673	CbGeAlD
Metformin—NDUFA6—pancreas—pancreatic cancer	0.00102	0.00673	CbGeAlD
Metformin—NDUFB4—pancreas—pancreatic cancer	0.001	0.0066	CbGeAlD
Metformin—NDUFAB1—pancreas—pancreatic cancer	0.000993	0.00656	CbGeAlD
Metformin—NDUFB9—pancreas—pancreatic cancer	0.000987	0.00652	CbGeAlD
Metformin—NDUFA8—pancreas—pancreatic cancer	0.000987	0.00652	CbGeAlD
Metformin—NDUFA4—pancreas—pancreatic cancer	0.000981	0.00648	CbGeAlD
Metformin—NDUFA10—digestive system—pancreatic cancer	0.000977	0.00645	CbGeAlD
Metformin—NDUFV1—pancreas—pancreatic cancer	0.000975	0.00644	CbGeAlD
Metformin—NDUFB11—pancreas—pancreatic cancer	0.000975	0.00644	CbGeAlD
Metformin—NDUFB8—pancreas—pancreatic cancer	0.00097	0.0064	CbGeAlD
Metformin—NDUFS5—pancreas—pancreatic cancer	0.00097	0.0064	CbGeAlD
Metformin—NDUFB2—digestive system—pancreatic cancer	0.00096	0.00634	CbGeAlD
Metformin—ND6—digestive system—pancreatic cancer	0.000944	0.00623	CbGeAlD
Metformin—NDUFA5—digestive system—pancreatic cancer	0.000915	0.00604	CbGeAlD
Metformin—NDUFS1—digestive system—pancreatic cancer	0.000901	0.00595	CbGeAlD
Metformin—NDUFB10—digestive system—pancreatic cancer	0.000895	0.00591	CbGeAlD
Metformin—NDUFB7—digestive system—pancreatic cancer	0.000889	0.00587	CbGeAlD
Metformin—NDUFS8—digestive system—pancreatic cancer	0.000882	0.00583	CbGeAlD
Metformin—NDUFB1—digestive system—pancreatic cancer	0.000882	0.00583	CbGeAlD
Metformin—NDUFB5—digestive system—pancreatic cancer	0.000871	0.00575	CbGeAlD
Metformin—NDUFA6—digestive system—pancreatic cancer	0.000871	0.00575	CbGeAlD
Metformin—NDUFS4—digestive system—pancreatic cancer	0.000865	0.00571	CbGeAlD
Metformin—NDUFB4—digestive system—pancreatic cancer	0.000854	0.00564	CbGeAlD
Metformin—NDUFAB1—digestive system—pancreatic cancer	0.000848	0.0056	CbGeAlD
Metformin—NDUFB9—digestive system—pancreatic cancer	0.000843	0.00557	CbGeAlD
Metformin—NDUFA8—digestive system—pancreatic cancer	0.000843	0.00557	CbGeAlD
Metformin—NDUFA4—digestive system—pancreatic cancer	0.000838	0.00553	CbGeAlD
Metformin—NDUFV1—digestive system—pancreatic cancer	0.000833	0.0055	CbGeAlD
Metformin—NDUFB11—digestive system—pancreatic cancer	0.000833	0.0055	CbGeAlD
Metformin—PRKAB1—pancreas—pancreatic cancer	0.000831	0.00549	CbGeAlD
Metformin—NDUFS5—digestive system—pancreatic cancer	0.000828	0.00547	CbGeAlD
Metformin—NDUFB8—digestive system—pancreatic cancer	0.000828	0.00547	CbGeAlD
Metformin—NDUFS7—digestive system—pancreatic cancer	0.000776	0.00512	CbGeAlD
Metformin—NDUFS2—pancreas—pancreatic cancer	0.000753	0.00497	CbGeAlD
Metformin—NDUFS3—pancreas—pancreatic cancer	0.000744	0.00491	CbGeAlD
Metformin—PRKAB1—digestive system—pancreatic cancer	0.00071	0.00469	CbGeAlD
Metformin—NDUFC2—digestive system—pancreatic cancer	0.000669	0.00442	CbGeAlD
Metformin—NDUFS2—digestive system—pancreatic cancer	0.000643	0.00425	CbGeAlD
Metformin—NDUFS3—digestive system—pancreatic cancer	0.000635	0.00419	CbGeAlD
Metformin—ND1—pancreas—pancreatic cancer	0.000618	0.00408	CbGeAlD
Metformin—ND1—digestive system—pancreatic cancer	0.000527	0.00348	CbGeAlD
Metformin—SLC22A2—digestive system—pancreatic cancer	0.000423	0.0028	CbGeAlD
Metformin—SLC47A1—digestive system—pancreatic cancer	0.000358	0.00237	CbGeAlD
Metformin—Chills—Docetaxel—pancreatic cancer	0.000181	0.00128	CcSEcCtD
Metformin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00018	0.00128	CcSEcCtD
Metformin—Asthenia—Sunitinib—pancreatic cancer	0.00018	0.00128	CcSEcCtD
Metformin—Decreased appetite—Irinotecan—pancreatic cancer	0.00018	0.00128	CcSEcCtD
Metformin—Dyspnoea—Gemcitabine—pancreatic cancer	0.00018	0.00128	CcSEcCtD
Metformin—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000179	0.00127	CcSEcCtD
Metformin—Somnolence—Gemcitabine—pancreatic cancer	0.000179	0.00127	CcSEcCtD
Metformin—Migraine—Doxorubicin—pancreatic cancer	0.000179	0.00127	CcSEcCtD
Metformin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000179	0.00127	CcSEcCtD
Metformin—Fatigue—Irinotecan—pancreatic cancer	0.000178	0.00127	CcSEcCtD
Metformin—Paraesthesia—Fluorouracil—pancreatic cancer	0.000178	0.00127	CcSEcCtD
Metformin—Pruritus—Sunitinib—pancreatic cancer	0.000178	0.00126	CcSEcCtD
Metformin—Breast disorder—Epirubicin—pancreatic cancer	0.000177	0.00126	CcSEcCtD
Metformin—Constipation—Irinotecan—pancreatic cancer	0.000177	0.00126	CcSEcCtD
Metformin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000177	0.00126	CcSEcCtD
Metformin—Somnolence—Fluorouracil—pancreatic cancer	0.000176	0.00125	CcSEcCtD
Metformin—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000175	0.00125	CcSEcCtD
Metformin—Erythema—Docetaxel—pancreatic cancer	0.000175	0.00125	CcSEcCtD
Metformin—Malnutrition—Docetaxel—pancreatic cancer	0.000175	0.00125	CcSEcCtD
Metformin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000175	0.00125	CcSEcCtD
Metformin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000174	0.00124	CcSEcCtD
Metformin—Nausea—Tamoxifen—pancreatic cancer	0.000174	0.00124	CcSEcCtD
Metformin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000174	0.00124	CcSEcCtD
Metformin—Fatigue—Gemcitabine—pancreatic cancer	0.000174	0.00124	CcSEcCtD
Metformin—Constipation—Gemcitabine—pancreatic cancer	0.000172	0.00123	CcSEcCtD
Metformin—Nausea—Erlotinib—pancreatic cancer	0.000172	0.00123	CcSEcCtD
Metformin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000172	0.00122	CcSEcCtD
Metformin—Diarrhoea—Sunitinib—pancreatic cancer	0.000172	0.00122	CcSEcCtD
Metformin—Dysgeusia—Docetaxel—pancreatic cancer	0.000172	0.00122	CcSEcCtD
Metformin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000171	0.00122	CcSEcCtD
Metformin—Abdominal distension—Epirubicin—pancreatic cancer	0.000171	0.00121	CcSEcCtD
Metformin—Feeling abnormal—Irinotecan—pancreatic cancer	0.00017	0.00121	CcSEcCtD
Metformin—Influenza—Epirubicin—pancreatic cancer	0.00017	0.00121	CcSEcCtD
Metformin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000169	0.0012	CcSEcCtD
Metformin—Dehydration—Doxorubicin—pancreatic cancer	0.000169	0.0012	CcSEcCtD
Metformin—Muscle spasms—Docetaxel—pancreatic cancer	0.000168	0.0012	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000168	0.00119	CcSEcCtD
Metformin—Pancreatitis—Epirubicin—pancreatic cancer	0.000166	0.00118	CcSEcCtD
Metformin—Dizziness—Sunitinib—pancreatic cancer	0.000166	0.00118	CcSEcCtD
Metformin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000166	0.00118	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000166	0.00118	CcSEcCtD
Metformin—Angina pectoris—Epirubicin—pancreatic cancer	0.000165	0.00118	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—pancreatic cancer	0.000164	0.00117	CcSEcCtD
Metformin—Abdominal pain—Irinotecan—pancreatic cancer	0.000163	0.00116	CcSEcCtD
Metformin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000163	0.00116	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000162	0.00115	CcSEcCtD
Metformin—Vomiting—Sunitinib—pancreatic cancer	0.00016	0.00114	CcSEcCtD
Metformin—Neutropenia—Epirubicin—pancreatic cancer	0.000159	0.00113	CcSEcCtD
Metformin—Rash—Sunitinib—pancreatic cancer	0.000158	0.00113	CcSEcCtD
Metformin—Dermatitis—Sunitinib—pancreatic cancer	0.000158	0.00113	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—pancreatic cancer	0.000158	0.00112	CcSEcCtD
Metformin—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000158	0.00112	CcSEcCtD
Metformin—Urticaria—Fluorouracil—pancreatic cancer	0.000157	0.00112	CcSEcCtD
Metformin—Headache—Sunitinib—pancreatic cancer	0.000157	0.00112	CcSEcCtD
Metformin—Syncope—Docetaxel—pancreatic cancer	0.000157	0.00112	CcSEcCtD
Metformin—Influenza—Doxorubicin—pancreatic cancer	0.000157	0.00112	CcSEcCtD
Metformin—Palpitations—Docetaxel—pancreatic cancer	0.000155	0.0011	CcSEcCtD
Metformin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000154	0.0011	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000154	0.00109	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—pancreatic cancer	0.000153	0.00109	CcSEcCtD
Metformin—Hypertension—Docetaxel—pancreatic cancer	0.000151	0.00108	CcSEcCtD
Metformin—Drowsiness—Epirubicin—pancreatic cancer	0.000151	0.00108	CcSEcCtD
Metformin—Infestation NOS—Epirubicin—pancreatic cancer	0.000151	0.00108	CcSEcCtD
Metformin—Infestation—Epirubicin—pancreatic cancer	0.000151	0.00108	CcSEcCtD
Metformin—Chest pain—Docetaxel—pancreatic cancer	0.000149	0.00106	CcSEcCtD
Metformin—Myalgia—Docetaxel—pancreatic cancer	0.000149	0.00106	CcSEcCtD
Metformin—Nausea—Sunitinib—pancreatic cancer	0.000149	0.00106	CcSEcCtD
Metformin—Asthenia—Irinotecan—pancreatic cancer	0.000148	0.00106	CcSEcCtD
Metformin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000148	0.00105	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000148	0.00105	CcSEcCtD
Metformin—Neutropenia—Doxorubicin—pancreatic cancer	0.000147	0.00104	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000146	0.00104	CcSEcCtD
Metformin—Asthenia—Gemcitabine—pancreatic cancer	0.000145	0.00103	CcSEcCtD
Metformin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000143	0.00102	CcSEcCtD
Metformin—Oedema—Docetaxel—pancreatic cancer	0.000143	0.00102	CcSEcCtD
Metformin—Pruritus—Gemcitabine—pancreatic cancer	0.000143	0.00101	CcSEcCtD
Metformin—Infection—Docetaxel—pancreatic cancer	0.000142	0.00101	CcSEcCtD
Metformin—Diarrhoea—Irinotecan—pancreatic cancer	0.000141	0.00101	CcSEcCtD
Metformin—Shock—Docetaxel—pancreatic cancer	0.000141	0.001	CcSEcCtD
Metformin—Nervous system disorder—Docetaxel—pancreatic cancer	0.00014	0.000997	CcSEcCtD
Metformin—Pruritus—Fluorouracil—pancreatic cancer	0.00014	0.000997	CcSEcCtD
Metformin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00014	0.000996	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—pancreatic cancer	0.00014	0.000995	CcSEcCtD
Metformin—Infestation—Doxorubicin—pancreatic cancer	0.00014	0.000995	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—pancreatic cancer	0.00014	0.000995	CcSEcCtD
Metformin—Skin disorder—Docetaxel—pancreatic cancer	0.000139	0.000988	CcSEcCtD
Metformin—Bradycardia—Epirubicin—pancreatic cancer	0.000138	0.000983	CcSEcCtD
Metformin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000138	0.000981	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000137	0.000975	CcSEcCtD
Metformin—Dizziness—Irinotecan—pancreatic cancer	0.000137	0.000973	CcSEcCtD
Metformin—Anorexia—Docetaxel—pancreatic cancer	0.000136	0.000969	CcSEcCtD
Metformin—Rhinitis—Epirubicin—pancreatic cancer	0.000136	0.000968	CcSEcCtD
Metformin—Hepatitis—Epirubicin—pancreatic cancer	0.000136	0.000966	CcSEcCtD
Metformin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000136	0.000964	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000135	0.000961	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000134	0.000951	CcSEcCtD
Metformin—Hypotension—Docetaxel—pancreatic cancer	0.000134	0.00095	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000133	0.000949	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000132	0.000941	CcSEcCtD
Metformin—Vomiting—Irinotecan—pancreatic cancer	0.000131	0.000935	CcSEcCtD
Metformin—Dizziness—Fluorouracil—pancreatic cancer	0.000131	0.000932	CcSEcCtD
Metformin—Rash—Irinotecan—pancreatic cancer	0.00013	0.000928	CcSEcCtD
Metformin—Dermatitis—Irinotecan—pancreatic cancer	0.00013	0.000927	CcSEcCtD
Metformin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00013	0.000927	CcSEcCtD
Metformin—Headache—Irinotecan—pancreatic cancer	0.00013	0.000922	CcSEcCtD
Metformin—Paraesthesia—Docetaxel—pancreatic cancer	0.000128	0.000913	CcSEcCtD
Metformin—Vomiting—Gemcitabine—pancreatic cancer	0.000128	0.000911	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—pancreatic cancer	0.000128	0.000909	CcSEcCtD
Metformin—Dyspnoea—Docetaxel—pancreatic cancer	0.000127	0.000907	CcSEcCtD
Metformin—Somnolence—Docetaxel—pancreatic cancer	0.000127	0.000904	CcSEcCtD
Metformin—Rash—Gemcitabine—pancreatic cancer	0.000127	0.000904	CcSEcCtD
Metformin—Dermatitis—Gemcitabine—pancreatic cancer	0.000127	0.000903	CcSEcCtD
Metformin—Eye disorder—Epirubicin—pancreatic cancer	0.000127	0.000902	CcSEcCtD
Metformin—Headache—Gemcitabine—pancreatic cancer	0.000126	0.000898	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000126	0.000896	CcSEcCtD
Metformin—Flushing—Epirubicin—pancreatic cancer	0.000126	0.000896	CcSEcCtD
Metformin—Vomiting—Fluorouracil—pancreatic cancer	0.000126	0.000896	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—pancreatic cancer	0.000126	0.000896	CcSEcCtD
Metformin—Dyspepsia—Docetaxel—pancreatic cancer	0.000126	0.000895	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—pancreatic cancer	0.000126	0.000893	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000125	0.000889	CcSEcCtD
Metformin—Rash—Fluorouracil—pancreatic cancer	0.000125	0.000888	CcSEcCtD
Metformin—Dermatitis—Fluorouracil—pancreatic cancer	0.000125	0.000888	CcSEcCtD
Metformin—Decreased appetite—Docetaxel—pancreatic cancer	0.000124	0.000884	CcSEcCtD
Metformin—Headache—Fluorouracil—pancreatic cancer	0.000124	0.000883	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000124	0.00088	CcSEcCtD
Metformin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000123	0.000878	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000123	0.000878	CcSEcCtD
Metformin—Fatigue—Docetaxel—pancreatic cancer	0.000123	0.000877	CcSEcCtD
Metformin—Angiopathy—Epirubicin—pancreatic cancer	0.000123	0.000876	CcSEcCtD
Metformin—Nausea—Irinotecan—pancreatic cancer	0.000123	0.000874	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—pancreatic cancer	0.000123	0.000872	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000122	0.00087	CcSEcCtD
Metformin—Constipation—Docetaxel—pancreatic cancer	0.000122	0.00087	CcSEcCtD
Metformin—Chills—Epirubicin—pancreatic cancer	0.000122	0.000866	CcSEcCtD
Metformin—Nausea—Gemcitabine—pancreatic cancer	0.00012	0.000851	CcSEcCtD
Metformin—Erythema—Epirubicin—pancreatic cancer	0.000118	0.00084	CcSEcCtD
Metformin—Malnutrition—Epirubicin—pancreatic cancer	0.000118	0.00084	CcSEcCtD
Metformin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000118	0.000838	CcSEcCtD
Metformin—Nausea—Fluorouracil—pancreatic cancer	0.000118	0.000837	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—pancreatic cancer	0.000117	0.000835	CcSEcCtD
Metformin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000117	0.000832	CcSEcCtD
Metformin—Flushing—Doxorubicin—pancreatic cancer	0.000117	0.000829	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000117	0.000829	CcSEcCtD
Metformin—Flatulence—Epirubicin—pancreatic cancer	0.000116	0.000828	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—pancreatic cancer	0.000116	0.000823	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—pancreatic cancer	0.000114	0.000811	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—pancreatic cancer	0.000114	0.000808	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000113	0.000807	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000113	0.000805	CcSEcCtD
Metformin—Abdominal pain—Docetaxel—pancreatic cancer	0.000113	0.000804	CcSEcCtD
Metformin—Chills—Doxorubicin—pancreatic cancer	0.000113	0.000802	CcSEcCtD
Metformin—Vision blurred—Epirubicin—pancreatic cancer	0.000111	0.000792	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00011	0.00078	CcSEcCtD
Metformin—Erythema—Doxorubicin—pancreatic cancer	0.000109	0.000778	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—pancreatic cancer	0.000109	0.000778	CcSEcCtD
Metformin—Flatulence—Doxorubicin—pancreatic cancer	0.000108	0.000766	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000107	0.000762	CcSEcCtD
Metformin—Malaise—Epirubicin—pancreatic cancer	0.000107	0.000758	CcSEcCtD
Metformin—Syncope—Epirubicin—pancreatic cancer	0.000106	0.000754	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000105	0.000748	CcSEcCtD
Metformin—Palpitations—Epirubicin—pancreatic cancer	0.000104	0.000743	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000104	0.000739	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—pancreatic cancer	0.000103	0.000733	CcSEcCtD
Metformin—Asthenia—Docetaxel—pancreatic cancer	0.000103	0.00073	CcSEcCtD
Metformin—Hypertension—Epirubicin—pancreatic cancer	0.000102	0.000726	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000101	0.000722	CcSEcCtD
Metformin—Pruritus—Docetaxel—pancreatic cancer	0.000101	0.00072	CcSEcCtD
Metformin—Myalgia—Epirubicin—pancreatic cancer	0.000101	0.000716	CcSEcCtD
Metformin—Chest pain—Epirubicin—pancreatic cancer	0.000101	0.000716	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	9.99e-05	0.000711	CcSEcCtD
Metformin—Discomfort—Epirubicin—pancreatic cancer	9.94e-05	0.000707	CcSEcCtD
Metformin—Malaise—Doxorubicin—pancreatic cancer	9.86e-05	0.000701	CcSEcCtD
Metformin—Syncope—Doxorubicin—pancreatic cancer	9.8e-05	0.000697	CcSEcCtD
Metformin—Diarrhoea—Docetaxel—pancreatic cancer	9.78e-05	0.000696	CcSEcCtD
Metformin—Palpitations—Doxorubicin—pancreatic cancer	9.66e-05	0.000687	CcSEcCtD
Metformin—Oedema—Epirubicin—pancreatic cancer	9.64e-05	0.000686	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—pancreatic cancer	9.61e-05	0.000684	CcSEcCtD
Metformin—Infection—Epirubicin—pancreatic cancer	9.58e-05	0.000681	CcSEcCtD
Metformin—Shock—Epirubicin—pancreatic cancer	9.49e-05	0.000675	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—pancreatic cancer	9.46e-05	0.000673	CcSEcCtD
Metformin—Dizziness—Docetaxel—pancreatic cancer	9.45e-05	0.000673	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—pancreatic cancer	9.44e-05	0.000672	CcSEcCtD
Metformin—Hypertension—Doxorubicin—pancreatic cancer	9.44e-05	0.000671	CcSEcCtD
Metformin—Skin disorder—Epirubicin—pancreatic cancer	9.37e-05	0.000666	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—pancreatic cancer	9.32e-05	0.000663	CcSEcCtD
Metformin—Chest pain—Doxorubicin—pancreatic cancer	9.31e-05	0.000662	CcSEcCtD
Metformin—Myalgia—Doxorubicin—pancreatic cancer	9.31e-05	0.000662	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	9.24e-05	0.000658	CcSEcCtD
Metformin—Discomfort—Doxorubicin—pancreatic cancer	9.19e-05	0.000654	CcSEcCtD
Metformin—Anorexia—Epirubicin—pancreatic cancer	9.19e-05	0.000654	CcSEcCtD
Metformin—Vomiting—Docetaxel—pancreatic cancer	9.09e-05	0.000647	CcSEcCtD
Metformin—Rash—Docetaxel—pancreatic cancer	9.01e-05	0.000641	CcSEcCtD
Metformin—Hypotension—Epirubicin—pancreatic cancer	9.01e-05	0.000641	CcSEcCtD
Metformin—Dermatitis—Docetaxel—pancreatic cancer	9e-05	0.000641	CcSEcCtD
Metformin—Headache—Docetaxel—pancreatic cancer	8.96e-05	0.000637	CcSEcCtD
Metformin—Oedema—Doxorubicin—pancreatic cancer	8.92e-05	0.000635	CcSEcCtD
Metformin—Infection—Doxorubicin—pancreatic cancer	8.86e-05	0.000631	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.78e-05	0.000625	CcSEcCtD
Metformin—Shock—Doxorubicin—pancreatic cancer	8.78e-05	0.000624	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—pancreatic cancer	8.75e-05	0.000622	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—pancreatic cancer	8.73e-05	0.000621	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—pancreatic cancer	8.67e-05	0.000616	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—pancreatic cancer	8.66e-05	0.000616	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.62e-05	0.000614	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—pancreatic cancer	8.6e-05	0.000612	CcSEcCtD
Metformin—Somnolence—Epirubicin—pancreatic cancer	8.57e-05	0.00061	CcSEcCtD
Metformin—Anorexia—Doxorubicin—pancreatic cancer	8.5e-05	0.000605	CcSEcCtD
Metformin—Nausea—Docetaxel—pancreatic cancer	8.49e-05	0.000604	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—pancreatic cancer	8.49e-05	0.000604	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—pancreatic cancer	8.38e-05	0.000596	CcSEcCtD
Metformin—Hypotension—Doxorubicin—pancreatic cancer	8.34e-05	0.000593	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	8.32e-05	0.000592	CcSEcCtD
Metformin—Fatigue—Epirubicin—pancreatic cancer	8.31e-05	0.000591	CcSEcCtD
Metformin—Constipation—Epirubicin—pancreatic cancer	8.25e-05	0.000587	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.13e-05	0.000578	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—pancreatic cancer	8.01e-05	0.00057	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—pancreatic cancer	7.95e-05	0.000566	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—pancreatic cancer	7.95e-05	0.000565	CcSEcCtD
Metformin—Somnolence—Doxorubicin—pancreatic cancer	7.93e-05	0.000564	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.88e-05	0.000561	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—pancreatic cancer	7.85e-05	0.000559	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—pancreatic cancer	7.76e-05	0.000552	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	7.7e-05	0.000548	CcSEcCtD
Metformin—Fatigue—Doxorubicin—pancreatic cancer	7.69e-05	0.000547	CcSEcCtD
Metformin—Urticaria—Epirubicin—pancreatic cancer	7.66e-05	0.000545	CcSEcCtD
Metformin—Constipation—Doxorubicin—pancreatic cancer	7.63e-05	0.000543	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—pancreatic cancer	7.62e-05	0.000542	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—pancreatic cancer	7.35e-05	0.000523	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.3e-05	0.000519	CcSEcCtD
Metformin—Urticaria—Doxorubicin—pancreatic cancer	7.09e-05	0.000504	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—pancreatic cancer	7.05e-05	0.000502	CcSEcCtD
Metformin—Asthenia—Epirubicin—pancreatic cancer	6.92e-05	0.000492	CcSEcCtD
Metformin—Pruritus—Epirubicin—pancreatic cancer	6.82e-05	0.000485	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—pancreatic cancer	6.6e-05	0.000469	CcSEcCtD
Metformin—Asthenia—Doxorubicin—pancreatic cancer	6.4e-05	0.000455	CcSEcCtD
Metformin—Dizziness—Epirubicin—pancreatic cancer	6.38e-05	0.000454	CcSEcCtD
Metformin—Pruritus—Doxorubicin—pancreatic cancer	6.31e-05	0.000449	CcSEcCtD
Metformin—Vomiting—Epirubicin—pancreatic cancer	6.13e-05	0.000436	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—pancreatic cancer	6.1e-05	0.000434	CcSEcCtD
Metformin—Rash—Epirubicin—pancreatic cancer	6.08e-05	0.000433	CcSEcCtD
Metformin—Dermatitis—Epirubicin—pancreatic cancer	6.07e-05	0.000432	CcSEcCtD
Metformin—Headache—Epirubicin—pancreatic cancer	6.04e-05	0.00043	CcSEcCtD
Metformin—Dizziness—Doxorubicin—pancreatic cancer	5.9e-05	0.00042	CcSEcCtD
Metformin—Nausea—Epirubicin—pancreatic cancer	5.73e-05	0.000407	CcSEcCtD
Metformin—Vomiting—Doxorubicin—pancreatic cancer	5.67e-05	0.000404	CcSEcCtD
Metformin—Rash—Doxorubicin—pancreatic cancer	5.63e-05	0.0004	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—pancreatic cancer	5.62e-05	0.0004	CcSEcCtD
Metformin—Headache—Doxorubicin—pancreatic cancer	5.59e-05	0.000398	CcSEcCtD
Metformin—Nausea—Doxorubicin—pancreatic cancer	5.3e-05	0.000377	CcSEcCtD
Metformin—PRKAB1—Signaling Pathways—JAG1—pancreatic cancer	2.42e-05	0.000214	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH3—pancreatic cancer	2.41e-05	0.000214	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.4e-05	0.000213	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PPARG—pancreatic cancer	2.39e-05	0.000212	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMP—pancreatic cancer	2.38e-05	0.000211	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CB—pancreatic cancer	2.37e-05	0.00021	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—pancreatic cancer	2.35e-05	0.000208	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CD—pancreatic cancer	2.32e-05	0.000205	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CD—pancreatic cancer	2.32e-05	0.000205	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CD—pancreatic cancer	2.32e-05	0.000205	CbGpPWpGaD
Metformin—ND1—Metabolism—TYMS—pancreatic cancer	2.31e-05	0.000205	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—ND2—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—ND3—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—ND5—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—ND4—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—ND6—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTEN—pancreatic cancer	2.3e-05	0.000204	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CNR1—pancreatic cancer	2.29e-05	0.000202	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.24e-05	0.000198	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—GCG—pancreatic cancer	2.21e-05	0.000195	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CD—pancreatic cancer	2.18e-05	0.000193	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AGTR1—pancreatic cancer	2.11e-05	0.000186	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STK11—pancreatic cancer	2.08e-05	0.000184	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTEN—pancreatic cancer	2.05e-05	0.000182	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CB—pancreatic cancer	2.02e-05	0.000179	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CB—pancreatic cancer	2.02e-05	0.000179	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CB—pancreatic cancer	2.02e-05	0.000179	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—pancreatic cancer	2e-05	0.000177	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—pancreatic cancer	2e-05	0.000177	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—pancreatic cancer	2e-05	0.000177	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PRSS1—pancreatic cancer	1.97e-05	0.000175	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GLP1R—pancreatic cancer	1.92e-05	0.00017	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PIK3CA—pancreatic cancer	1.91e-05	0.000169	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CB—pancreatic cancer	1.9e-05	0.000168	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—DPYD—pancreatic cancer	1.89e-05	0.000167	CbGpPWpGaD
Metformin—ND1—Metabolism—APOE—pancreatic cancer	1.88e-05	0.000166	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—pancreatic cancer	1.88e-05	0.000166	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PRSS1—pancreatic cancer	1.84e-05	0.000163	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SMAD4—pancreatic cancer	1.82e-05	0.000161	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC2A2—pancreatic cancer	1.79e-05	0.000159	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HES1—pancreatic cancer	1.77e-05	0.000157	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PIK3CA—pancreatic cancer	1.75e-05	0.000155	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PIK3CA—pancreatic cancer	1.75e-05	0.000155	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PIK3CA—pancreatic cancer	1.75e-05	0.000155	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PIK3CA—pancreatic cancer	1.75e-05	0.000155	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTEN—pancreatic cancer	1.74e-05	0.000154	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTEN—pancreatic cancer	1.74e-05	0.000154	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTEN—pancreatic cancer	1.74e-05	0.000154	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ARG2—pancreatic cancer	1.71e-05	0.000151	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CG—pancreatic cancer	1.7e-05	0.00015	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTEN—pancreatic cancer	1.64e-05	0.000145	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARG—pancreatic cancer	1.64e-05	0.000145	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—ND6—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	0.000144	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ARG2—pancreatic cancer	1.59e-05	0.000141	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—pancreatic cancer	1.56e-05	0.000138	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—pancreatic cancer	1.55e-05	0.000138	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMP—pancreatic cancer	1.5e-05	0.000132	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CD—pancreatic cancer	1.49e-05	0.000132	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HIF1A—pancreatic cancer	1.49e-05	0.000132	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TSC2—pancreatic cancer	1.48e-05	0.000131	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APOE—pancreatic cancer	1.45e-05	0.000128	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—pancreatic cancer	1.45e-05	0.000128	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—pancreatic cancer	1.43e-05	0.000126	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—pancreatic cancer	1.43e-05	0.000126	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—pancreatic cancer	1.43e-05	0.000126	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—pancreatic cancer	1.43e-05	0.000126	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—pancreatic cancer	1.42e-05	0.000126	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMP—pancreatic cancer	1.39e-05	0.000123	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CD44—pancreatic cancer	1.39e-05	0.000123	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NFKBIA—pancreatic cancer	1.35e-05	0.00012	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH1—pancreatic cancer	1.34e-05	0.000119	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GCG—pancreatic cancer	1.33e-05	0.000118	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—pancreatic cancer	1.33e-05	0.000117	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—pancreatic cancer	1.31e-05	0.000116	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CB—pancreatic cancer	1.3e-05	0.000115	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGF—pancreatic cancer	1.3e-05	0.000115	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—pancreatic cancer	1.29e-05	0.000114	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—STK11—pancreatic cancer	1.25e-05	0.000111	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—pancreatic cancer	1.23e-05	0.000109	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—pancreatic cancer	1.23e-05	0.000109	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—pancreatic cancer	1.23e-05	0.000109	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GLP1R—pancreatic cancer	1.21e-05	0.000107	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—DPYD—pancreatic cancer	1.19e-05	0.000105	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—pancreatic cancer	1.18e-05	0.000105	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—pancreatic cancer	1.16e-05	0.000102	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CD—pancreatic cancer	1.15e-05	0.000102	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC2A2—pancreatic cancer	1.13e-05	9.96e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—pancreatic cancer	1.12e-05	9.95e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GLP1R—pancreatic cancer	1.12e-05	9.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.11e-05	9.83e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—DPYD—pancreatic cancer	1.11e-05	9.78e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMS—pancreatic cancer	1.08e-05	9.54e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC2A2—pancreatic cancer	1.05e-05	9.28e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.04e-05	9.16e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—pancreatic cancer	1.01e-05	8.9e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—pancreatic cancer	1.01e-05	8.9e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—pancreatic cancer	1.01e-05	8.9e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CB—pancreatic cancer	1e-05	8.88e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—pancreatic cancer	9.65e-06	8.54e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—pancreatic cancer	9.45e-06	8.36e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—pancreatic cancer	9.23e-06	8.17e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—pancreatic cancer	8.99e-06	7.95e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—pancreatic cancer	8.9e-06	7.88e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOE—pancreatic cancer	8.76e-06	7.76e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—pancreatic cancer	8.73e-06	7.72e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CD44—pancreatic cancer	8.72e-06	7.71e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—pancreatic cancer	8.67e-06	7.68e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—pancreatic cancer	8.51e-06	7.53e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GCG—pancreatic cancer	8.36e-06	7.4e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CD44—pancreatic cancer	8.12e-06	7.19e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—pancreatic cancer	8.04e-06	7.12e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—pancreatic cancer	7.94e-06	7.02e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—pancreatic cancer	7.93e-06	7.02e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—pancreatic cancer	7.91e-06	7e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—STK11—pancreatic cancer	7.86e-06	6.95e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—pancreatic cancer	7.84e-06	6.93e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GCG—pancreatic cancer	7.79e-06	6.89e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—pancreatic cancer	7.76e-06	6.87e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—pancreatic cancer	7.74e-06	6.85e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—pancreatic cancer	7.63e-06	6.76e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—STK11—pancreatic cancer	7.32e-06	6.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—pancreatic cancer	7.21e-06	6.38e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFB1—pancreatic cancer	7.19e-06	6.36e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—pancreatic cancer	7.05e-06	6.24e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CD—pancreatic cancer	6.95e-06	6.15e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMS—pancreatic cancer	6.76e-06	5.98e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—pancreatic cancer	6.66e-06	5.89e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—pancreatic cancer	6.48e-06	5.73e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMS—pancreatic cancer	6.3e-06	5.57e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—pancreatic cancer	6.12e-06	5.42e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CB—pancreatic cancer	6.06e-06	5.36e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—pancreatic cancer	6.01e-06	5.31e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—pancreatic cancer	5.92e-06	5.24e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—pancreatic cancer	5.66e-06	5.01e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOE—pancreatic cancer	5.5e-06	4.86e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—pancreatic cancer	5.24e-06	4.63e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOE—pancreatic cancer	5.12e-06	4.53e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—pancreatic cancer	5e-06	4.42e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	4.96e-06	4.39e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—pancreatic cancer	4.79e-06	4.24e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	4.62e-06	4.09e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—pancreatic cancer	4.46e-06	3.95e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	4.36e-06	3.86e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	4.06e-06	3.6e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	3.8e-06	3.36e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—pancreatic cancer	3.77e-06	3.33e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—pancreatic cancer	3.69e-06	3.27e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	3.54e-06	3.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—pancreatic cancer	3.51e-06	3.11e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—pancreatic cancer	3.28e-06	2.91e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—pancreatic cancer	3.06e-06	2.71e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—pancreatic cancer	3.02e-06	2.67e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	2.32e-06	2.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	2.16e-06	1.91e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—pancreatic cancer	1.89e-06	1.68e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—pancreatic cancer	1.76e-06	1.56e-05	CbGpPWpGaD
